Clinical Features and Outcome of Solid Pseudopapillary Neoplasm Differences Between Adults and Children

被引:113
作者
Lee, Seung Eun [1 ]
Jang, Jin-Young [1 ]
Hwang, Dae Wook [1 ]
Park, Kwi-Won [1 ]
Kim, Sun-Whe [1 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Surg, Seoul 110744, South Korea
关键词
D O I
10.1001/archsurg.143.12.1218
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives: To delineate the clinical and pathological characteristics of solid pseudopapillary neoplasm ( SPN), compare them between adults and children, and determine the predictive features suggesting malignant potential. Design: Retrospective analysis of patients who underwent surgery for a pathologically confirmed SPN. Setting: Tertiary care referral center. Patients: Sixty-two consecutive patients who underwent surgery for a pathologically confirmed SPN between 1985 and 2006. Main Outcome Measures: Demographic information and clinical presentation, radiological details, surgical data, pathological characteristics, postoperative course, and long-term survival. Results: Among 62 patients, 47 patients were adults ( mean age, 36 years; range, 18-63 years) and 15 patients were children ( mean age, 12 years; range, 8-13 years). A palpable mass was the most common presenting symptom in children ( 9 of 15; 60%) and an incidentally detected pancreatic mass, in adults ( 18 of 47; 38.3%) ( P= .001). The mean tumor size in children was significantly larger than in adults ( 8.0 vs 6.0 cm; P < .03). In children, the tumor was located in the head of the pancreas ( 10 of 15; 66.7%) and in adults, in the body or tail ( 38 of 47; 80.9%) ( P = .001). Nine patients ( 14.5%) had malignant SPN. There was no significant clinical factor suggesting malignant potential. Two patients had a tumor recurrence. They were still alive after debulking surgery. There were no tumor-related deaths. Conclusion: Solid pseudopapillary neoplasm had different clinical features in adults and children. Because long-term survival can be achieved, even with the synchronous or metachronous metastatic lesions, SPN should be treated aggressively, with complete resection, even if this requires metastatectomy.
引用
收藏
页码:1218 / 1221
页数:4
相关论文
共 25 条
[1]   Solid pseudopapiltary tumor of the pancreas: a multicenter study of 23 pediatric cases [J].
Choi, Seung Hoon ;
Kim, Seong Min ;
Oh, Jung Tak ;
Park, Jin Young ;
Seo, Jeong Meen ;
Lee, Suk Koo .
JOURNAL OF PEDIATRIC SURGERY, 2006, 41 (12) :1992-1995
[2]   Management of solid-pseudopapillary neoplasms of the pancreas: A comparison with standard pancreatic neoplasms [J].
de Castro, S. M. M. ;
Singhal, D. ;
Aronson, D. C. ;
Busch, O. R. C. ;
van Gulik, T. M. ;
Obertop, H. ;
Gouma, D. J. .
WORLD JOURNAL OF SURGERY, 2007, 31 (05) :1129-1134
[3]  
FRIED P, 1985, CANCER, V56, P2783, DOI 10.1002/1097-0142(19851215)56:12<2783::AID-CNCR2820561211>3.0.CO
[4]  
2-Q
[5]   Solid pseudopapillary neoplasms of the pancreas: An updated experience [J].
Goh, Brian K. P. ;
Tan, Yu-Meng ;
Cheow, Peng-Chung ;
Chung, Yaw-Fui Alexander ;
Chow, Pierce K. H. ;
Wong, Wai-Keong ;
Ooi, London L. P. J. .
JOURNAL OF SURGICAL ONCOLOGY, 2007, 95 (08) :640-644
[6]   A solid pseudopapillary tumor arising from the greater omentum followed by multiple metastases with increasing malignant potential [J].
Hibi, T ;
Ojima, H ;
Sakamoto, Y ;
Kosuge, T ;
Shimada, K ;
Sano, T ;
Sakamoto, M ;
Kitajima, M ;
Yamasaki, S .
JOURNAL OF GASTROENTEROLOGY, 2006, 41 (03) :276-281
[7]   Solid and papillary epithelial neoplasm of the pancreas in children [J].
Jung, SE ;
Kim, DY ;
Park, KW ;
Lee, SC ;
Jang, JJ ;
Kim, WK .
WORLD JOURNAL OF SURGERY, 1999, 23 (03) :233-236
[8]   Preoperative gemcitabine for unresectable, solid pseudopapillary tumour of the pancreas [J].
Maffuz, A ;
Bustamante, FD ;
Silva, JA ;
Torres-Vargas, S .
LANCET ONCOLOGY, 2005, 6 (03) :185-186
[9]   Solid-pseudopapillary tumor of the pancreas: A surgical enigma? [J].
Martin, RCG ;
Klimstra, DS ;
Brennan, MF ;
Conlon, KC .
ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (01) :35-40
[10]  
MATSUNOU H, 1990, CANCER, V65, P283, DOI 10.1002/1097-0142(19900115)65:2<283::AID-CNCR2820650217>3.0.CO